欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/5284/003
药品名称	Olmesartan Medoxomil/Hydrochlorthiazid Macleods 40/12,5 mg Filmtabletten
活性成分	hydrochlorothiazide 12.5 mg olmesartan medoxomil 40.0 mg
剂型	Film-coated tablet
上市许可持有人	Macleods Pharma Espana, S.L.U. Avenida Diagonal 409, 1a Planta 08008 Barcelona Spain
参考成员国 - 产品名称	Germany (DE)
互认成员国 - 产品名称	Italy (IT)
许可日期	2016/06/16
最近更新日期	2023/04/11
药物ATC编码	C09DA08 olmesartan medoxomil and diuretics
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载	Final SPC \| final_common_SPC_DE_H_5284_003_IA_021Date of last change:2023/04/11 Final PL \| final_common_PL_DE_H_5284_003_IA_021Date of last change:2023/04/11 Final Labelling \| final_common_LAB_DE_H_5284_003_IA_021Date of last change:2023/04/11 Final Product Information \| common-final-pl-5284(003)-V014Date of last change:2021/12/03 Final Product Information \| common-final-pl-5284(001)-V014Date of last change:2021/12/03 Final Product Information \| common-final-pl-5284(002)-V014Date of last change:2021/12/03 Final Product Information \| common-final-spc-5284(002)-V014Date of last change:2021/12/03 Final Product Information \| common-final-spc-5284(003)-V014Date of last change:2021/12/03 Final Product Information \| common-final-pl-5284(004)-V014Date of last change:2021/12/03 Final Product Information \| common-final-spc-5284(001)-V014Date of last change:2021/12/03 Final Product Information \| common-final-spc-5284(004)-V014Date of last change:2021/12/03
市场状态	Positive